Skip to content

A Clinical pilot study to evaluate effect of Nano Kanchanara Twak extract Capsule (Ayurvedic Medicine) in Hypothyroidism patients

Experimental and Pilot Clinical Evaluation of safety and efficacy of Nano Kanchanara (Bauhinia variegata Linn) Twak Extract in Hypothyroidism - YCNKET

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/05/042402
Enrollment
12
Registered
2022-05-06
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E039- Hypothyroidism, unspecified

Interventions

None listed

Sponsors

Dean Faculty Of Ayurved
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients of either gender with age group 20-60 Years (both years inclusive) 2) Elevated level of serum TSH more than normal range (i.e. 0.4 -5.0 μIU/ml) 3) Patients having clinical features of hypothyroidism- a. Puffiness of face and eyelids b. Peripheral edema c. Dry coarse skin d. Breathlessness e. Constipation f. Weakness g. Lethargy h. Fatigue i. Muscle ache j. Menstrual abnormality k. Hair loss

Exclusion criteria

Exclusion criteria: 1)Known case of any chronic and severe systemic disorder including IHD, CVA, uncontrolled Hypertension, uncontrolled diabetes, CRF, Active Malignancy Disease 2)Pregnant and lactating females 3)Known case of congenital hypothyroidism and secondary hypothyroidism

Design outcomes

Primary

MeasureTime frame
Effect on level of TSH valueTimepoint: The efficacy of treatment will be assessed on the level of TSH value at baseline and at the end of 90 days

Secondary

MeasureTime frame
1) Effect on subjective parameter on the basis of Billewicz Diagnostic Index and a standard gradation scale. 2) BMI 3) Lipid Profile 4) HemogramTimepoint: The efficacy of treatment will be assessed on the basis of Billewicz Diagnostic Index and a standard gradation scale and BMI at baseline and at the end of 15 days till 90 days. Lipid Profile, Hemogram will be assessed at baseline and at the end of 90 days

Countries

India

Contacts

Public ContactDr Yakshi Choudhary

Parul Institute Of Ayurved

dr.shaileshd@gmail.com9763104451

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026